A total of 145 nasal swabs were collected from ESRD patients (N = 115) and hospital personnel (N = 30) from a Dialysis unit in Chennai during the period September 2013 to October 2013. Initial isolation and identification of CoNS was done by standard biochemical methods. [4] Screening of CoNS for methicillin resistance was done by cefoxitin disc (30 μg) diffusion, MIC (agar dilution method) and interpreted as per CLSI guidelines (2012). High-level mupirocin resistance was detected by using mupirocin (200 μg) disc diffusion test, MIC (agar dilution method) and ileS2 gene PCR. [5] Among 135 CoNS, 79 (59%) isolates were found to be high level methicillin resistant (MIC = 256 μg/ml). 35 (26%) isolates were found to be high-level mupirocin resistant (MIC > 512 μg/ ml/mupA + ) [ Table 1 ]. The mupA gene PCR product was sequenced and submitted to NCBI database (Accession no: KJ002644) and used as a positive control.
The present study indicates increasing prevalence of high level mupirocin resistance mediated by mobile elements among CoNS which substantiates their role as a putative reservoir of mupA resistance gene for MRSA. Thus, continued surveillance for mupirocin resistance among staphylococci in the anterior nares of ESRD patients and hospital personnel is needed in order to avoid decolonization and treatment failure using mupirocin. use of Ciprofloxacin resulted in the emergence of strains with decreased susceptibility and finally into highly resistant strains. [1, 2] Azithromycin has been used as the preferred drug of choice in paediatric population where fluoroquinolones are contraindicated.
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Isolates of
Salmonella species recovered from blood of the patients admitted in a tertiary care hospital, Mumbai from 2009 to 2013 were identified and subjected to antibiotic susceptibility testing by modified Kirby-Bauer disc diffusion test referring Clinical and Laboratory Standards Institute guidelines. [3] The antibiotics tested were Ampicillin (10 mcg), Cotrimoxazole (25 mcg), Chloramphenicol (30 mcg), Ceftriaxone (30 mcg), Tetracycline (30 mcg), Ciprofloxacin (5 mcg). The isolates were tested for sensitivity to Azithromycin (15 mcg) employing European Committee on antimicrobial susceptibility testing disc diffusion guidelines for testing and interpretation [4] and were also tested for their minimum inhibitory concentrations (MIC) for Ciprofloxacin and Azithromycin. All Salmonella isolates were also subjected to the test for detection of extended spectrum beta-lactamases (ESBL).
A total of 129 strains of Salmonella species including 108 Salmonella typhi, 10 Salmonella serovar typhimurium, 07 Salmonella serovar enteritidis and 04 Salmonella serovar paratyphi. All were recovered during the 5 years span. All the Salmonella typhimurium isolates were recovered from the paediatric patients. All S. typhi isolates were sensitive to Ampicillin, Cotrimoxazole, Chloramphenicol and Teracycline. Ciprofloxacin MIC in one strain was <0.03 mcg/ml, in 26 strains 0.25 mcg/ml and in 22 strains ≥8 mcg/ml indicating that 45.8% strains are highly Ciprofloxacin resistant. No ESBL were detected in any of S. typhi isolates. All the strains recovered during 2012 and 2013 were sensitive to Azithromycin by disc diffusion test. MIC for Azithromycin in all the strains was ≤4 mcg/ml. No multidrug-resistant strain was recovered in the last 5 years from this region.
All paratyphi A were resistant to Ciprofloxacin. Of the 10 typhimurium isolates, 5 were sensitive AMP, COT, T, CHL, CTR and CP, 3 strains showed resistance to COT, CHL and CP whereas 2 strains were resistant to only CP. All Salmonella enteritidis isolates were sensitive to all the drugs tested except for CP. Emergence of high-level Ciprofloxacin resistance has been reported in S. typhimurium. [5] The antibiotic susceptibility profile is influenced by various factors including the selective pressure of the antibiotic commonly used. The various epidemiological
